22803

0

ZENITHDRUG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZENITH DRUGS LIMITED Share Price Today

ZENITH DRUGS LIMITED is currently trading at ₹40.6, down by ₹1.1 from the previous close. The stock touched an intraday high of ₹42.00 and a low of ₹40.60 during the latest trading session. Over the past one year, ZENITH DRUGS LIMITED has delivered a loss of 41.54%, while the stock has gained 1.13% in the last one month.

ZENITH DRUGS LIMITED performance

Today’s low Today’s high
₹ 40.60 ₹ 42.00
₹ 40.60
52 week low 52 week high
₹ 33.30 ₹ 78.95
₹ 40.60
Open Price ₹ 42.00
Prev. Close ₹ 41.70
Volume (Shares) 1600.00
Total traded value ₹ .64
Upper Circuit ₹ 50.00
Lower Circuit ₹ 33.40
info

Investment Returns

Over 1 Month 1.13% Over 3 Months -12.82% Over 6 Months -24.90% Over 1 Year -41.54%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZENITH DRUGS LIMITED fundamentals


  • Market cap (Cr) 69.60
  • P/E Ratio (TTM) 17.65
  • Beta 1.05
  • Book Value / share 43.69
  • Return on equity 10.88%
  • EPS (TTM) 2.42
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

ZENITH DRUGS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 171.22
Operating Expense 170.72
Net Profit 3.94
Net Profit Margin (%) 2.30
Earnings Per Share (EPS) 2.30
EBITDA 17.26
Effective Tax Rate (%) 25.71
Particulars MAR 2025 (Values in Cr)
Revenue 133.32
Operating Expense 126.41
Net Profit 7.16
Net Profit Margin (%) 5.37
Earnings Per Share (EPS) 4.18
EBITDA 16.18
Effective Tax Rate (%) 22.08
Particulars MAR 2024 (Values in Cr)
Revenue 131.62
Operating Expense 119.00
Net Profit 9.54
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 5.56
EBITDA 19.04
Effective Tax Rate (%) 25.50
Particulars MAR 2023 (Values in Cr)
Revenue 114.52
Operating Expense 109.10
Net Profit 4.88
Net Profit Margin (%) 4.26
Earnings Per Share (EPS) 122.03
EBITDA 10.29
Effective Tax Rate (%) 26.72
Particulars MAR 2022 (Values in Cr)
Revenue 91.66
Operating Expense 88.21
Net Profit 3.21
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 80.32
EBITDA 7.88
Effective Tax Rate (%) 27.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.31
ROE % 24.13
ROCE % 25.16
Total Debt to Total Equity 0.63
EBITDA Margin 12.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 443.04
ROE % 32.74
ROCE % 24.04
Total Debt to Total Equity 1.51
EBITDA Margin 8.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 302.27
ROE % 25.89
ROCE % 21.47
Total Debt to Total Equity 1.56
EBITDA Margin 8.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 40.46
ROE % 10.88
ROCE % 12.71
Total Debt to Total Equity 0.55
EBITDA Margin 10.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.28
ROE % 26.64
ROCE % 27.63
Total Debt to Total Equity 0.62
EBITDA Margin 13.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share 443.30
ROE % 31.92
ROCE % 24.70
Total Debt to Total Equity 1.38
EBITDA Margin 8.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 321.27
ROE % 28.55
ROCE % 24.14
Total Debt to Total Equity 1.43
EBITDA Margin 8.67
Particulars MAR 2021 (Values in Cr)
Book Value / Share 240.95
ROE % 37.88
ROCE % 27.83
Total Debt to Total Equity 1.70
EBITDA Margin 9.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.80
Total Assets 135.03
Total Liabilities 135.03
Total Equity 62.33
Share Outstanding 1
Price to Book Ratio 1.73
Return on Assets (%) 7.10
Return on Capital (%) 11.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 97.92
Total Liabilities 97.92
Total Equity 17.73
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.98
Return on Capital (%) 11.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 68.58
Total Liabilities 68.58
Total Equity 12.10
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.57
Return on Capital (%) 10.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 161.47
Total Liabilities 161.47
Total Equity 69.37
Share Outstanding 1
Price to Book Ratio 1.77
Return on Assets (%) 4.43
Return on Capital (%) 6.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.74
Total Assets 134.17
Total Liabilities 134.17
Total Equity 62.21
Share Outstanding 1
Price to Book Ratio 1.73
Return on Assets (%) 7.10
Return on Capital (%) 11.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 97.22
Total Liabilities 97.22
Total Equity 17.73
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 5.02
Return on Capital (%) 11.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.88
Total Assets 66.18
Total Liabilities 66.18
Total Equity 12.85
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.85
Return on Capital (%) 10.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.84
Total Assets 46.54
Total Liabilities 46.54
Total Equity 9.63
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.58
Return on Capital (%) 12.21
Particulars MAR 2024 (Values in Cr)
Net Income 13.44
Cash from Operations -8.97
Cash from Investing 26.00
Cash from Financing -4.47
Net change in Cash 8.52
Free Cash Flow -3.64
Particulars MAR 2023 (Values in Cr)
Net Income 6.65
Cash from Operations -2.94
Cash from Investing -0.26
Cash from Financing 4.99
Net change in Cash -0.04
Free Cash Flow 2.62
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.47
Cash from Investing -5.24
Cash from Financing 1.24
Net change in Cash 1.15
Free Cash Flow 9.05
Particulars MAR 2025 (Values in Cr)
Net Income 9.50
Cash from Operations 0.29
Cash from Investing -31.40
Cash from Financing 28.39
Net change in Cash -8.48
Free Cash Flow 32.57
Particulars MAR 2024 (Values in Cr)
Net Income 13.29
Cash from Operations -8.84
Cash from Investing -5.33
Cash from Financing 29.71
Net change in Cash 8.54
Free Cash Flow -7.42
Particulars MAR 2023 (Values in Cr)
Net Income 6.65
Cash from Operations -2.44
Cash from Investing -2.04
Cash from Financing 6.30
Net change in Cash -0.01
Free Cash Flow -0.76
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.15
Cash from Investing -3.04
Cash from Financing -0.82
Net change in Cash 1.04
Free Cash Flow 8.72
Particulars MAR 2021 (Values in Cr)
Net Income 4.60
Cash from Operations 0.47
Cash from Investing -1.42
Cash from Financing 2.88
Net change in Cash 0.56
Free Cash Flow 1.90
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 36.03 14.89 1.74 276.11 23.12 38.85
BLISS GVS PHARMA LTD 439.40 35.55 3.89 4648.37 118.35 447.35
CIPLA LTD 1375.05 27.23 3.22 111076.61 1165.55 1672.20
FERMENTA BIOTECH LIMITED 317.00 13.98 2.29 932.96 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 36.03 25.20 4.64 276.11 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 545.50 24.45 4.25 1577.07 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8548.30 111.64 24.48 21370.75 7630.00 10653.05
BLISS GVS PHARMA LTD 439.40 47.25 4.02 4648.37 118.35 447.35

ZENITH DRUGS LIMITED shareholding pattern

Holding
30.02%
69.97%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ZENITH DRUGS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
40.60 -2.63 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 41.60
  • 26 Days 41.80
  • 10 Days 41.90
  • 50 Days 42.40
  • 12 Days 41.90
  • 100 Days 45.20
  • 20 Days 41.80
  • 200 Days 52.00
40.45 PIVOT
First Support 37.90 First Resistance 42.65 Second Support 35.70 Second Resistance 45.20 Third Support 33.15 Third Resistance 47.40
RSI 45.81 ADX 25.26 MACD 0.31 Williams % R -74.17 Commodity Channel Index (CCI) -31.25
Date 2026-06-03 Week 21120.00 Same Day 16000.00 Month 10218.00
1 Year 1.05 3 Year 1.08
Over 1 Month
1.13% down
Over 1 Year
-41.54% down
Over 3 Months
-12.82% down
Over 3 Years
-27.48% down
Over 6 Months
-24.90% down
Over 5 Years
0.00% down

ZENITH DRUGS LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
17 Sep 2024 0.5 Final 18 Sep 2024 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zenith Drugs Ltd?

Answer Field

Zenith Drugs Ltd share price is for NSE ₹ 40.60 & for BSE ₹ 0.00 as on Jun 05 2026 10:33 AM.

What is the Market Cap of Zenith Drugs Ltd Share?

Answer Field

The market cap of Zenith Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 05 2026 10:33 AM.

What is the 52 Week High and Low of Zenith Drugs Ltd?

Answer Field

The 52 Week High and Low of Zenith Drugs Ltd for NSE is ₹ 78.95 and ₹ 33.30 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Zenith Drugs Ltd?

Answer Field

The 1 year returns on the stock has been -40.33%.

What is the P/E Ratio of Zenith Drugs Ltd Share?

Answer Field

As on Jun 05 2026 10:33 AM the price-to-earnings (PE) ratio for Zenith Drugs Ltd share is 17.65.

What is the PB ratio of Zenith Drugs Ltd Share?

Answer Field

As on Jun 05 2026 10:33 AM, the price-to-book (PB) ratio for Zenith Drugs Ltd share is 43.69.

How to Buy Zenith Drugs Ltd Share?

Answer Field

You can trade in Zenith Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zenith Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Zenith Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zenith Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|